Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Neil Woodford just snapped up a bargain stock you’ve probably never heard of

Neil Woodford’s new stock buy could be a great addition to your portfolio, says G A Chester.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Renowned fund manager Neil Woodford is well known for his big investments in blue-chip companies. FTSE 100 giants in the pharma and tobacco sectors — AstraZeneca, Imperial Brands, British American Tobacco and GlaxoSmithKline — are the top holdings in his flagship equity income fund.

However, he’s certainly not averse to looking for stocks outside the mega-caps. Indeed, the market was notified this week that he’s bought a £70m stake in a business that many readers have probably never heard of. The company in question only joined the stock market this time last year and is listed in the FTSE SmallCap index.

However, like Woodford, I’m not put off by this. The company has a long trading history (it was the building products division of conglomerate Hanson back in the day) and it’s a decent size, with a market cap of about £450m. Furthermore, it looks to be a bargain buy.

A big show of confidence

Forterra (LSE: FORT) announced this week that Woodford has taken a notifiable stake in the company. In one day’s dealing last Friday his holding crossed the disclosable thresholds of 5%, 10%, 11%, 12%, 13%, 14%, 15% and 16%. By the end of the day, he owned over 33m shares — 16.7% of Forterra.

Woodford’s £70m investment is a big show of confidence in one of the leading manufacturers of building products for the UK building and construction industry. It follows Forterra’s maiden annual results as a listed company, which were released last month. The results were in line with expectations and management said that “2017 has started well, building on the momentum seen in the second half of 2016”.

The City consensus earnings forecast for the current year is for growth of 8%, taking earnings per share (EPS) to 23.2p, giving a price-to-earnings (P/E) ratio of 9.9 at a share price of 230p. The P/E is below the value threshold of 10 and a further advance in EPS forecast for next year drops it to 9. Meanwhile, a prospective dividend yield of 3.9%, rising to 4.3%, only adds to the stock’s value credentials.

Branded business parks

While Forterra is a new investment for Woodford, Sirius Real Estate (LSE: DRX) is an existing holding that he’s just pumped more cash into. This leading operator of branded business parks in Germany has a similar market cap to Forterra, being £470m at a share price of 53.5p.

Sirius notified the market this week that Woodford has increased his holding in the company from 38.3m shares to 44.9m. The purchase gives him a 5.1% stake valued at £24m, and follows a trading statement from the company earlier this month ahead of annual results scheduled for late June.

Sirius said the results are set to be in line with expectations. The City consensus is for EPS of 3.75p, giving a P/E of 14.3, which falls to 12.9 next year on forecasts of 11% EPS growth. The rating is rather higher than Forterra’s — but still reasonable — and the trade-off is that Sirius has a higher prospective yield of 4.8%, rising to 5.2%.

I can see why Woodford’s keen on both stocks and their valuations suggest now could be a good time to buy them.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

How big a Stocks and Shares ISA is needed to earn £1,000 of passive income each month?

Christopher Ruane does the maths and explains how a Stocks and Shares ISA could potentially generate a four-figure monthly passive…

Read more »

Businessman hand stacking up arrow on wooden block cubes
US Stock

This iconic S&P 500 fashion stock is one of my favourite picks for 2026

Jon Smith explains why he's optimistic about the prospects for a S&P 500 company that has smashed the broader index…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

These analysts have updated their forecasts for the Rolls-Royce share price

Jon Smith takes notes from updated broker views for the Rolls-Royce share price and offers his opinion on where it…

Read more »

Three generation family are playing football together in a field. There are two boys, their father and their grandfather.
Investing Articles

How much do you need in a SIPP to target a passive retirement income of £555 a month?

Harvey Jones crunches the numbers to show how a SIPP investor could assemble a portfolio of FTSE 100 shares to…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

1 FTSE 250 share to consider for the coming decade

With a long-term approach to investing, our writer looks at one FTSE 250 share with a dividend yield north of…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

3 UK shares to consider for the long term

What will the world look like years from now? Nobody knows, but our writer reckons this trio of UK shares…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Martin Lewis just gave a brilliant presentation on the power of investing in stock market indexes like the FTSE 100

Had an investor stuck £1,000 in the FTSE 100 index a decade ago, they would have done much better than…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I asked ChatGPT if we’ll get a stock market crash or rally before Christmas and it said…

Harvey Jones asks artificial intelligence if the run-up to Christmas will be ruined by a stock market crash, and finds…

Read more »